Vaccines against Infectious Diseases

Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against which no effective preventive intervention measure is either available or practical. The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible.

  • Anthrax vaccines
  • Poliomyelitis vaccines
  • Tick-borne encephalitis vaccines
  • Haemophilus influenza type b vaccines
  • Rabies vaccines
  • Varicella and herpes zoster (shingles) vaccines
  • Human papilloma-virus vaccines
  • Rotavirus gastroenteritis vaccines
  • Yellow fever vaccines
  • Japanese encephalitis vaccines
  • Dengue fever vaccines
  • Typhoid fever vaccines
  • Pneumococcal vaccines
  • Tuberculosis vaccines
  • Measles vaccines
  • Rubella vaccines
  • Hepatitis vaccines
  • Cholera vaccines
  • Meningococcal vaccines
  • Influenza vaccines
  • Diphtheria vaccines
  • Mumps vaccines
  • Tetanus vaccines
  • Pertussis vaccines
  • Vaccines for emerging & re-emerging diseases

Related Conference of Vaccines against Infectious Diseases

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

Vaccines against Infectious Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in